TWO SIGMA INVESTMENTS, LP - ADAMAS PHARMACEUTICALS INC ownership

ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 87 filers reported holding ADAMAS PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of ADAMAS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$1,626,000
-46.7%
331,243
-42.7%
0.00%
-42.9%
Q2 2021$3,053,000
+48.8%
578,159
+35.3%
0.01%
+40.0%
Q1 2021$2,052,000
+171.4%
427,458
+144.9%
0.01%
+150.0%
Q4 2020$756,000
+31.9%
174,534
+25.5%
0.00%0.0%
Q3 2020$573,000
+92.3%
139,059
+138.8%
0.00%
+100.0%
Q3 2019$298,000
+73.3%
58,231
+110.1%
0.00%0.0%
Q2 2019$172,000
-42.1%
27,720
-33.5%
0.00%0.0%
Q1 2019$297,000
-55.5%
41,711
-46.7%
0.00%
-66.7%
Q4 2018$668,000
+18.7%
78,189
+293.4%
0.00%0.0%
Q4 2015$563,000
-27.9%
19,876
-33.3%
0.00%
-25.0%
Q2 2015$781,00029,8000.00%
Other shareholders
ADAMAS PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
C Partners Holding GmbH 1,662,128$29,037,0009.28%
GREAT POINT PARTNERS LLC 608,650$10,645,0004.68%
Opaleye Management Inc. 255,000$4,460,0002.07%
EMERALD MUTUAL FUND ADVISERS TRUST 326,530$5,721,0000.47%
Granite Point Capital Management, L.P. 61,813$1,076,0000.39%
WALL STREET ASSOCIATES 225,000$3,935,0000.37%
EMERALD ADVISERS, LLC 322,631$5,652,0000.28%
Spark Investment Management LLC 75,500$1,317,0000.18%
TFS CAPITAL LLC 98,443$1,722,0000.17%
PRIVATE ASSET MANAGEMENT INC 47,690$834,0000.14%
View complete list of ADAMAS PHARMACEUTICALS INC shareholders